Lichen Planus Following COVID ‐19 Infection and Vaccination. Matched Case–Control Study
Australasian Journal of Dermatology · 2025
DOI: 10.1111/ajd.14522 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australasian Journal of Dermatology, 2025. Verfasst von Paolo Giacomo Arduino und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Science, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Lichen Planus, COVID-19, COVID-19 Vaccines, Vaccination. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
New‐onset lichen planus (LP) development following COVID‐19 infection/vaccination is reported. Since case series cannot be used to study exposure–outcome associations, we designed this matched case–control study to investigate whether COVID‐19‐related events and de novo LP are associated.
Methods
Patients with histologically confirmed LP, newly diagnosed at the National Research Center of Dermato‐Venereology of Moscow (September 2020–December 2022), were considered. Sex/age/ethnicity‐matched controls attending the same Center in the same period for consultations on conditions unrelated to LP were selected. Cases/controls with known LP trigger factors were excluded. COVID‐19‐related events were: symptomatic COVID‐19 (PCR‐confirmed), and COVID‐19 vaccination (viral vector vaccine) occurred ≤ 1 month before the visit at the Center. The association between COVID‐19‐related events and LP was assessed with conditional (Mantel–Haenszel method) and unconditional (logistic regression analysis adjusted for sex, age, and smoking) analyses. Subgroup analysis, with COVID‐19 infection and vaccination treated separately, and sensitivity analysis on another group of patients with suspected LP, not confirmed histologically, were also made.
Results
Fifty‐five case–control pairs were considered. Mean age (51 years), sex (56.4% females) and ethnicity (100% whites) distributions were the same in both groups. Conditional and unconditional odds ratios resulted 7.50 (95% Confidence Interval – 95CI , 1.72–32.80), 4.45 ( 95CI , 1.63–12.15), respectively ( p < 0.05). Subgroup analysis confirmed the association between symptomatic infection and LP , while sensitivity analysis corroborated the results of the primary analysis.
Conclusions
This observational study, reporting a strong significant association between COVID‐19 infection/vaccination and de‐novo LP, suggests that COVID‐19‐related events, especially infection, could act as LP trigger factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Science, University of Turin, Turin, Italy.
- State Research Center of Dermato-Venereology and Cosmetology, Moscow, Russian Federation.
- Sechenov First Moscow State Medical University, Moscow, Russian Federation.
- Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
ORCID-Profile: Paolo Giacomo Arduino, Alexey Kubanov, Anna Vlasova, Andrey Martynov, Stefano Petti
Zitieren
APA
Arduino, P. G., Kubanov, A., Vlasova, A., Martynov, A., & Petti, S. (2025). Lichen Planus Following COVID ‐19 Infection and Vaccination. Matched Case–Control Study. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.14522
Vancouver
Arduino PG, Kubanov A, Vlasova A, Martynov A, Petti S. Lichen Planus Following COVID ‐19 Infection and Vaccination. Matched Case–Control Study. Australasian Journal of Dermatology. 2025. doi:10.1111/ajd.14522
BibTeX
@article{Arduino2025,
author = {Arduino, Paolo Giacomo and Kubanov, Alexey and Vlasova, Anna and Martynov, Andrey and Petti, Stefano},
title = {Lichen Planus Following COVID ‐19 Infection and Vaccination. Matched Case–Control Study},
journal = {Australasian Journal of Dermatology},
year = {2025},
doi = {10.1111/ajd.14522}
}
EUVIMED